Verastem, Inc. (VSTM)
6.67
+0.39
(+6.21%)
USD |
NASDAQ |
Feb 06, 16:00
6.68
+0.01
(+0.15%)
After-Hours: 20:00
Verastem SG&A Expense (TTM) : 67.48M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| CorMedix, Inc. | 75.56M |
| Anavex Life Sciences Corp. | 13.82M |
| ADMA Biologics, Inc. | 96.37M |
| Ocugen, Inc. | 27.76M |
| Zevra Therapeutics, Inc. | 73.39M |